Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features

C Bartosch, JM Lopes, E Oliva - Advances in anatomic pathology, 2011 - journals.lww.com
This review focuses on the most common diagnostic pitfalls and helpful morphologic and
immunohistochemical markers in the differential diagnosis between the different subtypes of …

Pathologic and molecular features of uterine carcinosarcomas

MA Lopez-Garcia, J Palacios - Seminars in diagnostic pathology, 2010 - Elsevier
Uterine carcinosarcomas (UCSs), formerly known as malignant mixed müllerian tumors, are
uncommon neoplasias that account for< 5% of uterine malignancies. Traditionally, UCSs …

A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium

DL Kolin, DC Costigan, F Dong… - The American Journal …, 2019 - journals.lww.com
An unusual subset of endometrial carcinoma, the mesonephric-like adenocarcinomas, are
morphologically and molecularly similar to mesonephric carcinoma, characterized by KRAS …

Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma

X Chen, Q Yan, S Li, L Zhou, H Yang, Y Yang, X Liu… - Cancer letters, 2012 - Elsevier
This study investigated the role of miR-206 in estrogen receptor-α (ERα)-positive
endometrial endometrioid adenocarcinoma (EEC). We profiled miR-206 expression in 30 …

Expression of immunomodulatory molecules PD-1, PD-L1, and PD-L2, and their relationship with clinicopathologic characteristics in endometrial cancer

N Sungu, M Yildirim, R Desdicioglu… - International Journal …, 2019 - journals.lww.com
Chemotherapeutic agents are not very effective in treating advanced endometrial cancers
(ECs). Recent studies have demonstrated the immune evasion mechanism of tumors and …

miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer

BL Li, C Lu, W Lu, T Yang, J Qu, X Hong, X Wan - Medical Oncology, 2013 - Springer
Endometrial cancer (EC) is the most common gynecologic malignancy, but the molecular
events involved in the development and progression of EC remain unclear. Certain …

[HTML][HTML] Enolase-1 is a therapeutic target in endometrial carcinoma

M Zhao, W Fang, Y Wang, S Guo, L Shu, L Wang… - Oncotarget, 2015 - ncbi.nlm.nih.gov
ENO1 plays a paradoxical role in driving the pathogenesis of tumors. However, the clinical
significance of ENO1 expression remains unclear and its function and modulatory …

Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy

DM Janzen, MA Rosales, DY Paik, DS Lee, DA Smith… - Cancer research, 2013 - AACR
Progesterone, an agonist for the progesterone receptor (PR), can be an efficacious and well-
tolerated treatment in endometrial cancer. The clinical use of progesterone is limited …

Elevated MiR-222-3p promotes proliferation and invasion of endometrial carcinoma via targeting ERα

B Liu, Q Che, H Qiu, W Bao, X Chen, W Lu, B Li… - PLoS …, 2014 - journals.plos.org
MicroRNAs play key roles in tumor proliferation and invasion. Here we show distinct
expression of miR-222-3p between ERα-positive and ERα-negative endometrial carcinoma …

Data set for the reporting of endometrial cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR)

X Matias-Guiu, CI Selinger, L Anderson… - International Journal …, 2022 - journals.lww.com
Endometrial cancer is one of the most common cancers among women. The International
Collaboration on Cancer Reporting (ICCR) developed a standardized endometrial cancer …